How many days before starting testosterone shots will a typical adult male patient with suspected hypogonadism (low sex hormone) have a testosterone test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Testosterone Testing Before Starting Testosterone Shots

Testosterone levels must be measured on two separate mornings before starting testosterone injections, with no specific minimum number of days required between the diagnosis and treatment initiation—the key is confirming persistent hypogonadism with repeat testing, not waiting a predetermined interval. 1, 2

Diagnostic Testing Timeline

The diagnostic process requires:

  • Two separate fasting morning testosterone measurements (drawn between 8-10 AM) to confirm persistently low levels (<300 ng/dL), as single measurements are insufficient due to assay variability and diurnal fluctuation 1, 2, 3
  • No mandated waiting period exists between the confirmatory tests and treatment initiation once hypogonadism is biochemically confirmed and symptoms are present 1, 4
  • Repeat testing should occur on a different day from the initial measurement, but guidelines do not specify a minimum interval between the two tests 2, 5

Complete Pre-Treatment Workup

Before starting testosterone shots, the following must be obtained:

  • Measure LH and FSH levels after confirming low testosterone to distinguish primary (testicular) from secondary (pituitary-hypothalamic) hypogonadism, as this has critical treatment implications for fertility preservation 1, 2
  • Free testosterone by equilibrium dialysis should be measured in men with borderline total testosterone or conditions affecting sex hormone-binding globulin 1, 2
  • Baseline hematocrit or hemoglobin must be documented, as hematocrit >54% is an absolute contraindication to starting therapy 1, 2
  • PSA level and digital rectal examination in men over 40 years, with PSA >4.0 ng/mL requiring urologic evaluation before initiating therapy 1

Critical Fertility Consideration

If the patient desires fertility in the near term, testosterone therapy is absolutely contraindicated—gonadotropin therapy (hCG plus FSH) must be used instead, as exogenous testosterone suppresses spermatogenesis and causes prolonged azoospermia 1, 2, 3

Common Clinical Pitfall

The most critical error is starting testosterone without confirming the patient does not desire fertility, as this causes irreversible suppression of sperm production that may persist for months to years after discontinuation 1. Approximately 20-30% of men receiving testosterone in the United States do not have documented low testosterone levels before treatment initiation, violating evidence-based guidelines 1.

Post-Initiation Monitoring

Once treatment begins with intramuscular testosterone cypionate or enanthate (typically 100-200 mg every 2 weeks):

  • First testosterone level check occurs 2-3 months after treatment initiation or any dose change, measured midway between injections (days 5-7), targeting mid-normal values of 500-600 ng/dL 1, 4, 2
  • Peak serum levels occur 2-5 days after injection, with return to baseline by days 10-14, explaining the "roller coaster" effect some patients experience 6, 1
  • Once stable levels are achieved, monitoring every 6-12 months is typically sufficient 1, 4

References

Guideline

Testosterone Injection Treatment for Male Hypogonadism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.

The Journal of clinical endocrinology and metabolism, 2018

Research

Testosterone Replacement Therapy for Male Hypogonadism.

American family physician, 2024

Guideline

Testosterone Replacement Therapy Duration and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Male hypogonadism.

Lancet (London, England), 2014

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What exercises are recommended for a male patient with confirmed hypogonadism (low testosterone) before starting testosterone replacement therapy (TRT)?
What is the approach to assessing and treating low free testosterone levels in a middle-aged or older male patient presenting with symptoms of hypogonadism, such as decreased libido, fatigue, or erectile dysfunction?
What treatment options are available for a 49-year-old man with hypogonadism (low free testosterone)?
What is the evaluation and treatment process for low basal testosterone levels, also known as hypogonadism?
Does Nuegenix (testosterone booster) increase testosterone levels?
What are the differential diagnoses for an adult patient with back pain radiating to the right outer thigh?
What is the recommended approach to managing stroke risk in patients with chronic versus paroxysmal atrial fibrillation (AF), considering factors such as anticoagulation therapy, Direct Oral Anticoagulants (DOACs) like apixaban (Eliquis), rivaroxaban (Xarelto), or dabigatran (Pradaxa), and vitamin K antagonists like warfarin (Coumadin)?
At what age should a female patient with average risk of breast cancer stop having mammogram screenings?
What is the role of a tryptase test in diagnosing and managing a patient with a history of severe allergic reactions, possibly anaphylaxis?
What is the 4K (four kallikrein) score in prostate cancer diagnosis?
Is it appropriate to increase the dose of Vyvanse (lisdexamfetamine) in a patient who has been taking 30mg for one week and is requesting a dose increase?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.